Machka K, Milatovic D
Eur J Clin Microbiol. 1987 Feb;6(1):59-62. doi: 10.1007/BF02097195.
The serum bactericidal activity of two newer quinolones, ciprofloxacin and ofloxacin, against 206 clinical bacterial isolates was determined in six male volunteers after oral administration of either 500 mg of ciprofloxacin or 200 mg of ofloxacin respectively. The highest bactericidal titers were achieved against Enterobacteriaceae 1 h after ciprofloxacin administration, ranging from 1:121 for indole-positive Proteus species to 1:30 for Serratia spp. Ofloxacin generated lower titers, ranging from 1:14 for indole-positive Proteus spp. to 1:2.5 for Enterobacter spp. Only low serum bactericidal titers were found for Pseudomonas aeruginosa, Acinetobacter spp. and gram-positive cocci. It is concluded that the activity of orally administered ciprofloxacin is superior to that of orally administered ofloxacin in the serum bactericidal test.
分别对6名男性志愿者口服500mg环丙沙星或200mg氧氟沙星后,测定了这两种新型喹诺酮类药物环丙沙星和氧氟沙星对206株临床分离菌的血清杀菌活性。环丙沙星给药后1小时,对肠杆菌科细菌的杀菌效价最高,吲哚阳性变形杆菌属的效价范围为1:121,沙雷菌属为1:30。氧氟沙星产生的效价较低,吲哚阳性变形杆菌属的效价范围为1:14,肠杆菌属为1:2.5。对于铜绿假单胞菌、不动杆菌属和革兰氏阳性球菌,仅发现较低的血清杀菌效价。结论是,在血清杀菌试验中,口服环丙沙星的活性优于口服氧氟沙星。